Every so often, investors overcomplicate things. They look for perfect timing, hidden gems, or clever angles, whereas some of the best opportunities come from owning outstanding businesses that have already proven themselves.

Within the ASX 200, there are shares with long track records, clear demand drivers, and business models built to endure.

Here are two ASX 200 shares that stand out as no-brainer buys for long-term investors.

Goodman Group (ASX: GMG)

Goodman Group could be a no-brainer buy at current prices, especially given how it has quietly become one of the most strategically important property businesses on the ASX.

Its focus on industrial, logistics, and data centre assets places it directly behind long-term structural trends such as ecommerce, supply chain optimisation, and digital infrastructure growth. These are not short-term themes. They are reshaping how goods and data move around the world.

What makes Goodman particularly compelling is its ability to combine property ownership with development and funds management. This allows it to recycle capital, grow earnings, and expand globally without relying solely on rising property values. For investors, that creates a powerful mix of stability and growth potential.

Morgan Stanley is a big fan of the company and sees a lot of value in its shares. Its analysts currently have an overweight rating and $41.50 price target on them. Based on its current share price of $30.94, this implies potential upside of 34% for investors over the next 12 months.

Macquarie Group Ltd (ASX: MQG)

Another ASX 200 share that could be a no-brainer buy for Aussie investors is Macquarie Group.

Unlike traditional banks, Macquarie operates across asset management, infrastructure investment, commodities, and financial services. This diversification allows it to perform across different market environments and pivot as opportunities change.

A key strength is Macquarie’s disciplined approach to risk and capital allocation. The group has shown a willingness to exit businesses when returns no longer stack up and redeploy capital into higher-quality opportunities. Over time, that mindset has helped it navigate volatility and continue growing shareholder value.

For investors seeking exposure to global markets and infrastructure through a well-managed ASX share, Macquarie stands out.

The team at Ord Minnett is feeling bullish about this ASX 200 share. Late last year, the broker upgraded Macquarie’s shares to a buy rating with a $255.00 price target. Based on its current share price of $215.19, this suggests that upside of 18.5% is possible for investors between now and this time next year.

The post These ASX 200 shares could be no-brainer buys appeared first on The Motley Fool Australia.

More reading

• If I had $5,000 to invest on the ASX today, this is how I’d split it
• UBS just rated ASX bank shares NAB, BOQ and Macquarie as a buy
• One ASX 200 giant to buy, one to hold, and one to sell
• 5 fantastic ASX shares to buy for an SMSF
• How to build a $50,000 portfolio with ASX 200 shares

Motley Fool contributor James Mickleboro has positions in Goodman Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

When building a long-term share portfolio, I think it pays to start with ASX shares you would feel comfortable owning through good markets, bad markets, and everything in between.

That usually means blue chip ASX shares with strong competitive positions, recurring demand for their products or services, and management teams that have proven they can execute over time.

With that in mind, here are four ASX blue chip shares I would happily build a portfolio around.

Cochlear Ltd (ASX: COH)

The first blue chip ASX share that could be a buy is Cochlear. This hearing solutions company operates in a specialised medical niche supported by intellectual property, regulatory approvals, and decades of clinical data. Once a patient adopts Cochlear’s technology, switching is rare, which helps create long-lasting revenue streams from upgrades and services.

The company’s consistent investment in research and development is also a key part of its appeal. By prioritising innovation and long-term outcomes over short-term gains, Cochlear has built a business designed to remain relevant for decades.

REA Group Ltd (ASX: REA)

Another blue chip ASX share I would happily build a portfolio around is REA Group. Its property platforms sit at the centre of Australia’s real estate ecosystem, benefiting from strong network effects that reinforce its market position. Buyers, sellers, and agents all rely on its services, which makes the business difficult to disrupt.

Importantly, REA is not dependent on rising property prices to grow. Product upgrades, premium services, and data-driven tools allow it to increase revenue per customer over time. This is supporting a sustainable and scalable business model.

ResMed Inc. (ASX: RMD)

A third blue chip ASX share that could be a buy is ResMed. It is a medical device company with demand drivers that extend well beyond economic cycles. The company operates in sleep apnoea and respiratory care, areas supported by ageing populations, rising diagnosis rates, and greater awareness of chronic health conditions.

Its devices, masks, and digital platforms are deeply entrenched in patient care, creating recurring revenue and strong customer relationships. And with a total addressable market estimated to be over 1 billion people, its long-term growth outlook is very positive.

TechnologyOne Ltd (ASX: TNE)

A final blue chip ASX share to consider is TechnologyOne. It is an enterprise software provider to governments, universities, and large organisations. Its move to a software-as-a-service model has transformed the business, improving revenue visibility and increasing recurring income.

TechnologyOne’s products are deeply embedded within customer operations, making them difficult to replace. Combined with ongoing international expansion, this gives it a rare mix of defensiveness and growth within a blue chip structure.

The post The ASX blue chip shares I’d happily build a portfolio around appeared first on The Motley Fool Australia.

More reading

• 3 unstoppable ASX 200 shares to buy and hold forever
• ASX Sectors to target and avoid in 2026: Expert
• The best Australian shares to buy in 2026
• 5 fantastic ASX shares to buy for an SMSF
• A rare buying opportunity in 1 of Australia’s top shares?

Motley Fool contributor James Mickleboro has positions in Cochlear, REA Group, ResMed, and Technology One. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear, ResMed, and Technology One. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Cochlear and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The AMP Ltd (ASX: AMP) share price is 0.69% higher at the time of writing on Tuesday afternoon, at $1.74 a piece.

For the year-to-date, the AMP share price is down 4.81% and it is currently 1.02% below levels seen this time last year.

What happened to the AMP share price?

It’s been a slow start for the Australian financial services company in 2026. Its shares slipped last week after news that a new CEO will take over the business spooked investors. 

Blair Vernon will take the reins as the company’s new CEO and sitting CEO, while Alexis George will retire from her executive roles on the 30th of March. George has served as AMP’s CEO since August 2021, overseeing a period of significant transformation and growth for the company.

AMP says the executive handover will be managed carefully to maintain stability and delivery of ongoing strategy. The board and new CEO will continue to focus on growth and customer outcomes as the company enters its next phase.

A formal search for AMP’s new Chief Financial Officer is expected to begin soon. The company says all incentives and contractual arrangements for George’s departure will proceed as previously disclosed.

The move has stirred up concerns about business uncertainty among investors. AMP has spent the past year or so reshaping its business after selling off its advice and insurance in August 2024. Its financial results have been patchy too. 

The fund manager released its third-quarter update in mid-October which saw its share price drop for the day. At the time, AMP revealed a 3.6% increase in total assets under management (AUM) to $159.5 billion. The increase was largely due to its platforms business, with net cash flows up 61.6%.

The superannuation & investments division experienced a net cash outflow of $214 million, which was much smaller than the $334 million lost in the prior corresponding period. Meanwhile, AMP’s total loan book increased by 1.3%.

The wealth manager did not issue any guidance for the rest of the financial year.

AMP is expected to report its results next month, followed by an annual general meeting on the 10th of April.

Is there any upside ahead?

Analysts seem to think so. In fact, the team at Citi recently upgraded its rating on the financial services company to a buy. The broker said it thinks the current share price is a great buying opportunity for investors. 

The broker also said it believes that AMP might announce a capital return with its results next month. 

TradingView data shows that not all analysts are quite as optimistic. Out of 11 analysts, 7 have a hold rating on AMP shares. The remainder have a buy or strong buy rating.

However the average target price is $1.97 a piece, which implies a potential 12.76% upside, at the time of writing. And some think the share price could storm even higher. The maximum target price is $2.20, which implies a potential 25.71% upside for investors.

The post AMP share price down 5% in 2026 so far. Is there any upside ahead? appeared first on The Motley Fool Australia.

More reading

• AMP shares sliding today on big leadership news
• AMP appoints Blair Vernon as CEO, Alexis George to retire
• Leading brokers name 3 ASX shares to buy today
• Own AMP shares? Here are your key dates for the year

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX All Ords Index (ASX: XAO) shares are up 0.95% to 9,277 points as a slew of stocks hit 52-week highs.

ASX mining shares dominate the list of companies hitting these new price milestones today.

Arguably, the most significant price peak today is for BHP Group Ltd (ASX: BHP) shares.

BHP reclaimed its place as the All Ords’ largest share by market capitalisation from Commonwealth Bank of Australia (ASX: CBA) today.

CBA took the title from BHP in July 2024 during an unprecedented run that took it to a record $191 per share in June 2025.

The CBA share price is $150.35 on Tuesday, up 0.85%, while BHP shares are $49.66, up 2.54%, at the time of writing.

The BHP share price hit a two-year high of $50.08 this morning, which is not far off its historical high of $50.84 reached in late 2023.

But today isn’t all about BHP shares.

Plenty of other ASX All Ords shares have smashed new multi-year highs as well.

Here’s a sample.

ASX All Ords shares reaching new price highs

As stated earlier, mining shares dominate the list of company highs today, so let’s focus on them first.

Besides BHP, two other large-cap ASX diversified miners hit new 52-week share price highs.

The Mineral Resources Ltd (ASX: MIN) share price rose 2.8% to a 52-week high of $64.05.

South32 Ltd (ASX: S32) shares hit a 52-week high of $4.54 per share, up 3.4%.

Among the ASX All Ords gold shares, Newmont Corporation CDI (ASX: NEM) lifted 1.9% to a record high of $181.91.

The Resolute Mining Ltd (ASX: RSG) share price soared 10.3% to a 52-week peak of $1.50.

Ramelius Resources Ltd (ASX: RMS) shares surged 3.5% to a record $5.09.

Regis Resources Ltd (ASX: RRL) shares increased 2.8% to a multi-year high of $8.58.

Copper and gold miner Firefly Metals Ltd (ASX: FFM) lifted 5.8% to a 52-week high of $2.20 per share.

Among ASX silver shares, Silver Mines Ltd (ASX: SVL) rose 12.5% to a 52-week high of 27 cents.

Canaccord Genuity sees more growth ahead for Sun Silver Ltd (ASX: SS1) shares, which rose 6.5% to a record $2.47 apiece today.

ASX All Ords lithium shares also hit new price peaks.

Shares in lithium and nickel producer IGO Ltd (ASX: IGO) increased 2% to a two-year high of $9.50.

The Winsome Resources Ltd (ASX: WR1) share price lifted 11.7% to an 18-month high of 67 cents.

Hot Chili Ltd (ASX: HCH) shares soared 9.2% to a 52-week high of $1.89.

Among ASX All Ords copper shares, Capstone Copper Corp CDI (ASX: CSC) soared 8.8% to a record $16.27 per share.

The Develop Global Ltd (ASX: DVP) share price rose 5.8% to a four-year high of $5.67.

What about ASX All Ords shares from other sectors?

ASX All Ords retail stock Nick Scali Limited (ASX: NCK) ascended 1.9% to a record $26.08 per share.

Engineering services company Monadelphous Group Ltd (ASX: MND) lifted 3.6% to a record $30.98.

Testing and inspection services provider ALS Ltd (ASX: ALQ) rose 1.4% to a record $24.41.

The post ASX All Ords shares smashing 52-week highs today appeared first on The Motley Fool Australia.

More reading

• Morgans names 3 ASX shares to buy
• 2 ASX mining shares up 200% in a year and tipped to keep rising
• Bye bye CBA: BHP is back as the ASX 200’s biggest stock
• BHP, Pro Medicus, Myer shares: Buy, hold, or sell?
• BHP share price cracks $50 as experts revise ratings following 1H FY26 update

Motley Fool contributor Bronwyn Allen has positions in BHP Group and South32. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group and Nick Scali. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

As an ASX 200 bank share, dividend investors have always been an important part of the investor base when it comes to National Australia Bank Ltd (ASX: NAB) shares. The four major ASX bank stocks have built up a reputation over many decades as some of the ASX’s most reliable payers of fat, and (mostly) fully-franked dividends.

NAB is no different. However, this particular bank stock has just come off one of the most dramatic share price rallies we have seen for years. And that has had a notable impact on the dividend yield one can obtain when buying NAB shares today.

With that in mind, let’s get into just how much in dividends investors can expect to receive from NAB if they buy this bank’s shares right now.

A record year for this ASX 200 bank stock

2025 was a volatile, though still successful, year for NAB. The bank saw a precipitous sell-off back in April thanks to the ructions that US President Donald Trump’s ‘Liberation Day’ tariffs sparked. This mini market meltdown saw the NAB share price drop from about $41 in late March to under $34 by 9 April. When those tariffs were walked back, though, NAB went on a tear. The bank rose by a whopping near-40% between early April and early November, finally topping out at $45.25 on 4 November.

Today, NAB shares have walked back from that 18-year high and are trading at just under $43 at the time of writing.

NAB paid out two dividends to shareholders over 2025, as is the bank’s habit. The first was the July interim dividend worth 85 cents per share. The second, the final dividend from December, is also worth 85 cents per share. Both payments came with full franking credits attached.

This annual total of $1.70 per share represented a modest 0.6% rise over the $1.69 investors bagged in 2024. At the current NAB share price, this gives this ASX 200 bank stock a trailing dividend yield of 3.96%.

How much will NAB shares pay in dividends in 2026 and beyond?

However, dividend yields always represent the past, not what investors can expect to receive going forward. Of course, we don’t yet know what kinds of dividends NAB has in store for shareholders in 2026. We won’t know until the bank shows its hand later in the year.

However, we have some projections investors can contemplate. Last week, my Fool colleague Tristan looked at some analyst predictions for what kind of income NAB might provide for its investors over the next few years.

Analysts have pencilled in a total payout of $1.70 per share over FY 2026. So no change there from 2025. If that does turn out to be the case, then NAB is indeed trading on a forward dividend yield of 3.96% today.

Those analysts have then predicted a FY 2027 dividend total of $1.705 per share, rising to $1.72 by FY 2028. If those modest predictions are on the money, they would give NAB shares a forward yield of 3.97% for FY 2027 and 4% for FY 2028.

The post Buying NAB shares? Here’s the dividend yield you’ll get today appeared first on The Motley Fool Australia.

More reading

• UBS just rated ASX bank shares NAB, BOQ and Macquarie as a buy
• Top brokers name 3 ASX shares to buy next week
• Brokers name 3 ASX shares to buy today
• NAB share price climbed another 3% on Thursday. What’s next for the banking giant in 2026?
• 3 ETFs I think could outperform NAB shares in 2026

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Another earnings surprise has put Mayfield Group Holdings Ltd (ASX: MYG) back in the spotlight.

The electrical infrastructure group released an earnings update today that caught the market off guard and sent its shares higher.

At the time of writing, the Mayfield share price is up 10.48% to $3.48, extending a stunning run that has seen the stock surge more than 310% over the past year.

Let’s dive into what the company announced during mid-afternoon trade.

Earnings guidance jumps sharply

According to the release, Mayfield released its earnings guidance for the half-year ended 31 December 2025.

The company expects unaudited NPAT of approximately $4.9 million for the half. That compares with $1.98 million in NPAT for the prior corresponding period and $7.47 million for the full year ended 30 June 2025.

Mayfield is now on track to deliver close to two-thirds of last year’s full-year profit in just six months. The figures came in well ahead of the market’s expectations.

Management did not provide revenue or margin detail in today’s release, but the earnings jump suggests demand remains strong across energy infrastructure, data centres, defence installations, and industrial projects.

A stock that just keeps delivering

Today’s update builds on the stock’s strong performance over the past year.

Mayfield shares were trading below $1 a year ago. Since then, improvements in earnings visibility, strong order flow, and consistent execution have driven a sharp increase in investor confidence.

The company designs, manufactures, and services critical electrical infrastructure, including switchboards, modular electrical rooms, and power systems. That exposure positions Mayfield directly in the path of Australia’s expanding energy transition, data centre build-out, and defence spending.

Importantly, much of this demand is non-discretionary. Power infrastructure still needs to be built and maintained regardless of economic conditions.

Brokers remain bullish

Broker sentiment has also played a role in today’s move.

According to market reports released this morning, Bell Potter lifted its price target on Mayfield to $3.60 per share, reflecting improved earnings expectations following the guidance update.

That target implies there may still be upside from current levels, even after the stock’s extraordinary run.

Earlier broker commentary has highlighted Mayfield’s scalable operating model, strong balance sheet, and ability to convert revenue growth into profits.

What’s next?

Despite the strong run over the past year, today’s update indicates the business continues to perform well.

The company is due to release its full half-year results next month. That update should include more detail on margins, cash flow, and order books.

The post This ASX small cap is rocketing 10% today. Here’s why appeared first on The Motley Fool Australia.

More reading

• Leading brokers name 3 ASX shares to buy today
• 3 ASX 200 shares that look like cheap buys to me
• 3 Australian stocks tipped to grow 100% (or more) in 2026
• Why is the Coronado share price tanking 9% today
• Forget CBA shares: I’m buying shares in another Aussie bank

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Mayfield Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are listed below. Here’s why they are bullish on them:

CSL Ltd (ASX: CSL)

According to a note out of Citi, its analysts have retained their buy rating and $225.00 price target on this biotherapeutics company’s shares. The broker highlights that CSL shares were sold off in 2025 amid concerns over margins, influenza vaccine demand, immunoglobulins growth, and Seqirus uncertainty. It believes there is scope for a recovery in 2026 even if its net profits don’t grow in the double-digits. Citi thinks that rebuilding investor confidence will be more important than beating earnings estimates. The CSL share price is trading at $183.18 on Tuesday afternoon.

Life360 Inc (ASX: 360)

A note out of Bell Potter reveals that its analysts have retained their buy rating on this location technology company’s shares with a reduced price target of $45.00. Bell Potter was impressed with Life360’s performance in the fourth quarter and FY 2025. It highlights that its trading update was ahead of both guidance and its forecasts. This includes monthly active users rising to 95.8 million (vs Bell Potter’s estimate of 93.5 million), paying circles of 2.83 million (vs Bell Potter’s estimate of 2.8 million), and adjusted EBITDA of between US$87 million and US$92 million (vs Bell Potter’s estimate of US$86 million). And with management guiding to monthly active user growth of 20% in 2026, the broker is feeling very positive about its outlook. And while its valuation has been reduced to reflect a re-rating of tech valuations, it still sees plenty of upside for investors. The Life360 share price is fetching $31.03 at the time of writing.

Pro Medicus Ltd (ASX: PME)

Analysts at Macquarie have upgraded this health imaging technology company’s shares to an outperform rating with a trimmed price target of $291.30. According to the note, the broker made the move on valuation grounds following significant share price weakness. In addition, it has received industry feedback that indicates that Pro Medicus is likely to continue winning market share over the near term. It also believes that its AI offering will strengthen the Visage offering and cement its leadership position. The Pro Medicus share price is trading at $188.00 this afternoon.

The post Leading brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

More reading

• 3 ASX 200 shares that look like cheap buys to me
• Why DroneShield, Life360, Nova Minerals, and Santana shares are falling today
• Why Dateline, EOS, Karoon Energy, and Pro Medicus shares are charging higher today
• Down 10% today: Should you buy Life360 shares?
• BHP, Pro Medicus, Myer shares: Buy, hold, or sell?

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has positions in CSL, Life360, and Pro Medicus. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Life360, and Macquarie Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Life360 and Macquarie Group. The Motley Fool Australia has recommended CSL and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

When I’m looking for cheap shares on the S&P/ASX 200 Index (ASX: XJO), I’m not just chasing low valuation multiples or stocks that have fallen sharply. 

What I really want are high-quality businesses where the share price has weakened more than the long-term investment case has deteriorated.

Right now, there are a few ASX 200 names where sentiment looks overly pessimistic to me. These are three that I would genuinely consider at current levels.

CSL Ltd (ASX: CSL)

CSL is one of those rare companies that almost never looks cheap, which is why the current share price stands out. The biotech stock has been under pressure as investors reacted to a cacophony of headwinds hitting at once. This includes a slower CSL Behring margin recovery, weak US influenza vaccine sales, and albumin softness in China.

However, the long-term story still looks intact to me. CSL remains dominant in its key immunoglobulins market, continues to invest heavily in capacity and R&D, and has a long history of working through short-term disruptions.

At today’s share price, market expectations are clearly very low. For a business of CSL’s quality, that is often where longer-term opportunities start to emerge for investors.

Amcor Plc (ASX: AMC)

Amcor is a stock that I think the market is overlooking. Ongoing volume weakness has weighed on the share price.

What changes the picture for me is the acquisition of Berry Global. This was a genuinely game-changing transaction, creating a global packaging leader with significantly greater scale, broader customer relationships, and improved exposure across flexible and rigid packaging markets.

Execution will matter, particularly around integration and cost synergies. But if management delivers, the combined group has the potential to generate stronger cash flows and more resilient earnings than Amcor could on its own. At current levels, I think the market is still heavily discounting that longer-term upside.

James Hardie Industries Plc (ASX: JHX)

James Hardie has been caught up in concerns about the US housing cycle, higher interest rates, slowing construction activity, and the large acquisition of Azek. That has pushed the share price down sharply.

Yet the business remains a clear leader in fibre cement products, with strong brand recognition and meaningful exposure to repair and renovation activity. Housing cycles turn, and when they do, James Hardie has historically been well placed to benefit.

If US housing conditions stabilise over time, the earnings leverage in this business could become very apparent from current levels.

Foolish Takeaway

When I look at the quality of these businesses against the expectations implied by their current share prices, all three look more attractive to me than they have in quite a while.

For patient, long-term investors, that’s often where the best opportunities begin to form.

The post 3 ASX 200 shares that look like cheap buys to me appeared first on The Motley Fool Australia.

More reading

• Leading brokers name 3 ASX shares to buy today
• Here are the latest growth forecasts for the CSL share price
• Buy, hold, sell: CSL, CBA, and Rio Tinto shares
• The best Australian shares to buy in 2026
• $10,000 in these ASX dividend shares pays how much passive income?

Motley Fool contributor Grace Alvino has positions in CSL. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has positions in and has recommended Amcor Plc. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Australian share market has had a subdued start to 2026, with many stocks struggling to gain traction over the past few weeks. But there are some Australian stocks which analysts have tipped to rocket in 2026.

Here are three of them, all tipped to climb by more than 100% in the next 12 months!

WiseTech Global (ASX: WTC) 

The WiseTech share price is 1.94% higher in Tuesday afternoon trade. At the time of writing, the shares are changing hands for $63.09 each. That’s a 7.99% decline for the year so far, and a huge 47.28% below where the stock was trading at this time last year.

A number of headwinds have put the logistics software provider’s stock under pressure in 2025, but WiseTech still has strong growth potential ahead of it this year.

The business is strong; it is continually expanding its operations and has a proven track record of company growth, even amid volatility. 

Analysts are incredibly bullish about the outlook for the tech shares. TradingView data shows that 12 out of 14 have a strong buy rating on the stock, and another has a buy rating. The maximum target price is $175.65, which implies the shares could jump a whopping 178.28% this year, at the time of writing.

EBR Systems Inc (ASX: EBR)

EBR Systems is a Silicon Valley-based medical device company that has developed Wireless Stimulation Endocardially (WiSE®) technology. It is the world’s only wireless, leadless left ventricular pacing device for heart failure patients.

The technology helps to treat individuals with cardiac rhythm diseases by sending electrical stimulation directly to the heart. It conducts operations in the US, but it’s primary listing is on the ASX.

At the time of writing, its shares are down 3.19% to 91 cents each. It means the shares are now 48.59% below where they were this time last year.

The Australian stock has reached some excellent milestones over the past year, including the first implant of its WiSE technology and strong Q4 FY25 commercial and clinical progress. 

Analysts are bullish on the outlook of EBR Systems in 2026. TradingView data shows all four analysts have a strong buy rating, with a maximum target price of $2.97 a piece. That implies a potential 226.12% upside at the time of writing. Even the minimum target price of $2.43 implies a potential 167.32% upside in 2026.

Zip Co Ltd (ASX: ZIP)

Zip shares have had a disappointing start to 2026 so far. The shares are down 2.14% today to $2.98 a piece. For the year to date, the stock has dropped 11.19% and it’s now 5.08% below this time last year.

But I think the latest decline represents a great opportunity for investors to get into high-quality stock at a cheap price.

Zip has posted some strong financial results over the past few quarters, and the business has some great growth plans in place for 2026. 

The company is expected to post its FY26 half-year results in February, at which point investors will find out if the company is still on track. Good news could push the share price higher over a short period of time. I think the stock is a screaming buy for 2026.

Analysts are optimistic too. TradingView data shows that 9 out of 11 analysts have a buy or strong buy rating on the stock. The maximum target price is $6.72, which, at the time of writing, implies a potential 126.26% upside ahead over the next 12 months. 

The post 3 Australian stocks tipped to grow 100% (or more) in 2026 appeared first on The Motley Fool Australia.

More reading

• Morgans names 3 ASX shares to buy
• Why experts have put buy recommendations on these ASX shares
• The best Australian shares to buy in 2026
• Top brokers name 3 ASX shares to buy next week
• Forget PLS shares! This ASX growth stock is tipped to rise 60% by 2027

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Coronado Global Resources Inc (ASX: CRN) share price is under heavy pressure today, making it one of the ASX’s worst performers.

At the time of writing, the Coronado share price is down 8.78% to 44.7 cents, wiping out a chunk of recent gains. By comparison, the S&P/ASX All Ordinaries Index (ASX: XAO) is up 0.7%.

Despite today’s sharp fall, Coronado shares are up almost 40% so far in 2026, supported by a strong rally in metallurgical coal prices.

So, what’s going on?

A sharp pullback after a strong run

Coronado’s share price has staged a solid rebound over recent months, tracking the recovery in met coal markets.

However, after such a fast move higher, the stock appears to be taking a breather. Today’s decline looks more like a pullback than a breakdown, especially given the broader context.

Coking coal, also known as metallurgical coal, is down 0.61% today, according to Trading Economics, but remains up around 13% over the past month. That suggests prices may simply be pausing after a strong rally, rather than starting a sustained decline.

Met coal remains the key driver

Coronado is a pure-play metallurgical coal producer, supplying coal used in steelmaking rather than power generation.

Demand for met coal is closely tied to global steel production, infrastructure spending, and industrial activity. Over recent months, improved sentiment around steel demand and tighter supply conditions have helped lift prices.

As long as met coal prices remain elevated compared to last year’s lows, Coronado’s earnings outlook looks much stronger than it did in 2025.

What the charts are saying

From a technical point of view, Coronado shares were looking a bit stretched before today’s fall.

The relative strength index (RSI), a momentum indicator, had moved into the high 60s and low 70s. That often signals a stock may be due for a pullback.

On the chart, support sits around the low 40-cent level, with stronger support closer to 38 to 40 cents. If selling pressure continues, those levels will be worth watching.

On the upside, resistance remains near 50 cents, which has capped recent rallies.

Coronado also has a high beta, meaning it tends to move more sharply than the broader ASX market. That helps explain why the share price has fallen so sharply today.

Foolish Takeaway

Today’s sell-off is painful, especially for short-term holders.

But Coronado’s strong gains in 2026 show how quickly sentiment can change when coal prices move. If met coal prices remain firm, today’s drop may turn out to be a short-term setback rather than a downward trend.

The post Why is the Coronado share price tanking 9% today appeared first on The Motley Fool Australia.

More reading

• Up 16% in 2026 already – is this ASX small-cap a buy?
• Investors are buying this ASX coal stock again today. Here’s why
• Coronado shares surge 12% after Monday’s sell-off
• Why 4DMedical, Coronado Global, Metallium, and WiseTech Global shares are falling today
• Coronado shares plummet after mine fatality in Queensland

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.